Accessibility Menu
Alcidion Group logo

Alcidion Group(ASX) ALC

Market CapA$120.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)+41%
5 Year-75%
1 Year-21%
1 Month-5%
A$0.09
+1.11%
+0.00Today
Alcidion Group last closing stock price
MetricPriceDate
Last closeAUD 0.092026-08-13
Alcidion Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.15%AUD 0.092026-08-06
1 month-5.21%AUD 0.102026-07-14
3 month-8.08%AUD 0.102026-05-15
Year to date-13.33%AUD 0.112025-12-31
1 year-20.87%AUD 0.122025-08-13
3 year-20.87%AUD 0.122023-08-14
5 year-74.72%AUD 0.362021-08-13
Since inception+41.15%AUD 0.062015-08-19

Alcidion Group Financials at a Glance

Market Cap

A$120.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$84.25M

Net Income (TTM)

-A$1.10M

EPS (TTM)

A$0.00

P/E Ratio

31.03

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Price

A$0.09

Volume

0

Open

A$0.09

Previous Close

A$0.09

Daily Range

A$0.09 - A$0.09

52-Week Range

A$0.08 - A$0.15

Estimated Earnings Date

Sep 2, 2026

ALC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alcidion Group

Alcidion Group Limited operates as a healthcare technology firm, specializing in the creation and licensing of software products across Australia, New Zealand, and the United Kingdom. The company focuses on enabling intelligent healthcare delivery through its innovative solutions.

Products and Services
  • Miya Precision: A platform built on the FHIR standard for healthcare delivery
  • Smartpage: A mobile and web-based system for hospital communications
  • Patientrack: A tool for real-time patient monitoring and risk screening
Growth Outlook
  • Recent quarterly revenue reached AUD 25.47 million, indicating strong demand
  • Trailing twelve months (TTM) revenue shows a growth trend, reflecting market expansion
  • Positive cash flow from operations in the latest quarter supports future investments
Financial Highlights
  • Net income for the latest quarter was AUD 1.33 million, showcasing profitability
  • Operating income margin improved to 8.64%, indicating operational efficiency
  • Cash and cash equivalents stood at AUD 14.2 million, providing liquidity for growth
Alcidion Group Limited is positioned in the healthcare information services industry, focusing on innovative software solutions that enhance patient care and streamline hospital operations. The company's flagship product, Miya Precision, leverages the Fast Healthcare Interoperability Resources (FHIR) standard, which is crucial for modern healthcare interoperability. The diverse product portfolio, including Smartpage and Patientrack, addresses various needs within healthcare settings, from communication to patient monitoring. The growth outlook for Alcidion is promising, with recent quarterly revenue reflecting strong market demand and a positive trajectory in TTM revenue. The latest financial results indicate a net income of AUD 1.33 million, highlighting the company's ability to generate profit. Additionally, the operating income margin has improved, suggesting enhanced operational efficiency. With a solid cash position, Alcidion is well-equipped to pursue further growth opportunities in the evolving healthcare technology landscape.
AI Generated • Jul 26, 2026

Industry

Health Care Technology

Employees

136

CEO

Kate Quirke

Headquarters

South Yarra, VIC 3141, AU

ALC Financials

Key Financial Metrics (TTM)

Gross Margin

52.93%

Operating Margin

17.46%

Net Income Margin

7.97%

Return on Equity

4.37%

Return on Capital

8.75%

Return on Assets

3.28%

Earnings Yield

3.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$120.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.34B

Volume

0

Avg. Volume

819.69K

Financials (TTM)

Gross Profit

A$56.28M

Operating Income

A$10.17M

EBITDA

A$4.91M

Operating Cash Flow

A$7.49M

Capital Expenditure

-A$165.00K

Free Cash Flow

A$7.33M

Cash & ST Invst.

A$14.20M

Total Debt

A$1.32M

Alcidion Group Performance Analysis

Alcidion Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 34,355,000N/A
20232023-06-30AUD 40,400,00017.6%
20242024-06-30AUD 37,057,000-8.3%
20252025-06-30AUD 40,786,00010.1%
Alcidion Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-5.6%
Q22024-12-31-2.0%
Q42025-06-3031.2%
Q22025-12-3110.0%
Alcidion Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.00N/A
20232023-06-30AUD -0.00-26.3%
20242024-06-30AUD -0.01128.6%
20252025-06-30AUD 0.00N/A
Alcidion Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3011.8%
Q22024-12-3176.7%
Q42025-06-30371.4%
Q22025-12-31-47.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$25.47M

+33.6%

Gross Profit

A$5.11M

+537.5%

Gross Margin

20.06%

N/A

Market Cap

A$120.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$889.12K

N/A

Employees

136

N/A

Net Income

A$1.33M

+130.7%

EBITDA

A$4.57M

+257.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$14.20M

+79.4%

Total Debt

A$1.32M

-36.6%

Accounts Receivable

A$10.72M

+26.8%

Inventory

A$0.00

N/A

Long Term Debt

A$636.00K

-52.2%

Short Term Debt

A$680.00K

-54.3%

Return on Assets

3.28%

N/A

Return on Invested Capital

8.87%

N/A

Free Cash Flow

-A$2.60M

+77.4%

Operating Cash Flow

-A$2.56M

+77.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RCE.AXRecce Pharmaceuticals Ltd
A$0.38+0.00%
VLS.AXVita Life Sciences Limited
A$2.49+0.00%
ONE.AXOneview Healthcare PLC
A$0.16+0.00%
ALA.AXArovella Therapeutics Limited
A$0.06+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.56+0.02%
CDECoeur Mining
$18.45-0.02%
TAT&T
$24.58+0.01%
SMRNuScale Power
$9.85+0.03%

Questions About ALC

What is the current price of Alcidion Group?

Alcidion Group is trading at A$0.09 per share.

What is the 52-week range for Alcidion Group?

Over the past 52 weeks, Alcidion Group has traded between A$0.08 and A$0.15.

How much debt does Alcidion Group have?

As of the most recent reporting period, Alcidion Group reported total debt of A$1.41M.

How much cash does Alcidion Group have on hand?

Alcidion Group reported A$17.70M in cash and cash equivalents in its most recent financial results.

What is Alcidion Group’s dividend yield?

Alcidion Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.